Status:
SUSPENDED
Nociception Evaluated by the NOL® Index in Sedated Patients in the Intensive Care Unit
Lead Sponsor:
University of Chile
Conditions:
Nociceptive Pain
Sedation Complication
Eligibility:
All Genders
18-70 years
Brief Summary
Due to their underlying pathology and the necessary complicated procedures to which they are exposed, patients in the intensive care unit experience varying degrees of pain at some point in their evol...
Detailed Description
In the following protocol, we will study the feasibility of using the NOL® index to evaluate nociception in patients under sedation with propofol and opioid analgesics such as fentanyl. This study ai...
Eligibility Criteria
Inclusion
- ICU sedated patients under propofol and fentanyl
Exclusion
- Sedation duration less than 72 h
- Stroke
- Opioid user before ICU hospitalization
- Atrial fibrillation
- Pregnancy/lactation
- Patient with antiarrhythmic agents
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 20 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05399758
Start Date
June 1 2022
End Date
July 20 2023
Last Update
July 19 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Investigación Cínica Avanzada (CICA), Hospital Clinico de la Universidad de Chile
Santiago, RM, Chile, 7690306
2
Hospital Clinico de la Universidad de Chile
Santiago, RM, Chile, 7690306